Kyrgyzfarmatsiya delegation discusses centralized drug procurement in Kazakhstan

12:55, 30 июня 2026, Bishkek - 24.kg news agency , Anastasia BENGARD

A delegation from the state-owned enterprise Kyrgyzfarmatsiya paid a working visit to Almaty, where they held talks with SK-Pharmacy LLP, the sole distributor of medicines and medical devices in Kazakhstan.

According to the state enterprise, during the meeting, the parties discussed promising areas of bilateral cooperation aimed at improving the centralized drug supply system.

Key agenda items:

• development of mechanisms for centralized and consolidated procurement of medicines and medical devices;
• exchange of practical experience in organizing public procurement and drug supply;
• development of cooperation with domestic and international manufacturers;
• improvement of logistics processes and ensuring sustainable supply;
• study of Kazakhstan’s successful experience in centralized drug supply.

The delegation also visited the modern logistics hub of SK-Pharmacy LLP, certified in accordance with the international standard of Good Distribution Practice (GDP).

During the familiarization visit, company representatives studied the organization of warehouse logistics, storage requirements for medicines and medical devices, the temperature monitoring system, storage conditions for heat-sensitive products, the processes for receiving, picking, and shipping goods, as well as mechanisms for ensuring quality, traceability, and product safety at all stages of the supply chain.

The experience gained will be used in the implementation of projects to develop the modern logistics infrastructure of Kyrgyzfarmatsiya, including the creation of its own warehouse complex that meets international GDP standards.

Kyrgyzfarmatsiya was established in March 2023 to improve the availability of medicines in public hospitals. However, patients have repeatedly reported problems.

According to Order No. 1 of the Ministry of Health dated January 1, 2026, the state enterprise centrally procures 191 medications. Medical institutions may purchase any medications not included in this list independently.